AnalystBook Research · Company Intelligence

Alto Ingredients, Inc.

ALTONasdaq

Built from Alto Ingredients, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Alto Ingredients revenue fell 4.9% to $917.9M, but net income turned positive at $13.3M and free cash flow turned positive.

The read at a glance✓ Audited against SEC data
  • Business mixSpecialty alcohols and renewable fuelsNote
  • RevenueRevenue fell 4.9% to $917.9MWatch
  • ProfitabilityNet income turned positiveOK
  • CashFree cash flow turned positiveOK
  • DebtDebt fell 15.1%OK
  • Insiders1 buy / 0 sellsNote
  • AccountingAltman-Z grey; EQ safeNote

Business

Alto Ingredients produces and distributes specialty alcohols, renewable fuels, and essential ingredients in the United States.

Leadership changes

From Alto Ingredients, Inc.'s own filings, the day they're filed.

  • Jeremy T. Bezdek · member · departureeff. 2025-11-24
  • Michael D. Kandris · director · departureeff. 2025-06-25
  • Douglas L. Kieta · Chairman · departureeff. 2025-03-17

Latest filings

  • 8-K · Company announcement2026-08-07
  • 10-Q · Quarterly report2026-08-07
  • 8-K · Company announcement2026-08-05
  • 8-K · Company announcement2026-06-23
  • 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Alto Ingredients, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.